SCHEMBL14809341

SCHEMBL14809341

CCOP(C)(=O)c1ccc(C=O)cc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.41
ALDH1A3 P47895 2/20 0.41
ALDH3A1 P30838 1/20 0.41
CYP2A6 P11509 3/20 0.39
AOX1 Q06278 1/20 0.39
LMNA P02545 2/20 0.38
KMT2A Q03164 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
NR1I2 O75469 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TYR P14679 1/20 0.35
CYP2A13 Q16696 1/20 0.35
ACHE P22303 1/20 0.35
KDM4E B2RXH2 1/20 0.35
NEK2 P51955 1/20 0.35
HDAC1 Q13547 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10168109 0.83 TDP1 (0.51) ALDH1A1ALDH1A3ALDH3A1CYP2A6AOX1
SCHEMBL14820812 0.80 KMT2A (0.45) ALDH1A1AOX1KMT2ANR1I2MAPT
SCHEMBL5488946 0.79 HPGD (0.52) ALDH1A1LMNAKMT2AMAPTHPGD
SCHEMBL29449953 0.77 GAA (0.46) LMNAKMT2AMAPTHPGDACHE
SCHEMBL777146 0.76 ACHE (0.56) ALDH1A1AOX1LMNAKMT2ANR1I2
SCHEMBL12258671 0.76 AOX1 (0.45) ALDH1A1ALDH1A3ALDH3A1CYP2A6AOX1
SCHEMBL11609892 0.76 MMP9 (0.45) ALDH1A1LMNAKMT2ANR1I2MAPT
SCHEMBL13536556 0.73 CYP2A6 (0.50) ALDH1A1ALDH1A3ALDH3A1CYP2A6HPGD
SCHEMBL22655783 0.73 LPL (0.42) ALDH1A1LMNAKMT2AHDAC1
SCHEMBL440134 0.73 ALDH1A1 (0.44) ALDH1A1ALDH1A3ALDH3A1CYP2A6AOX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2758059-B1 SUBSTITUTED PYRIMIDINES MERCK SHARP & DOHME (US) 2018-10-24 EP disclosed
US-9079930-B2 Substituted pyrimidines MERCK SHARP & DOHME CORP. (US) 2015-07-14 US disclosed
US-9079930-B2 Substituted pyrimidines MERCK SHARP & DOHME CORP. (US) 2015-07-14 US disclosed
US-9079930-B2 Substituted pyrimidines MERCK SHARP & DOHME CORP. (US) 2015-07-14 US disclosed
US-20140349972-A1 SUBSTITUTED PYRIMIDINES MERCK SHARP & DOHME CORP (US) 2014-11-27 US disclosed
US-20140349972-A1 SUBSTITUTED PYRIMIDINES MERCK SHARP & DOHME CORP (US) 2014-11-27 US disclosed
US-20140349972-A1 SUBSTITUTED PYRIMIDINES MERCK SHARP & DOHME CORP (US) 2014-11-27 US disclosed
EP-2758059-A1 SUBSTITUTED PYRIMIDINES Merck Sharp & Dohme Corp. (US) 2014-07-30 EP disclosed
WO-2013043624-A1 SUBSTITUTED PYRIMIDINES MERCK SHARP & DOHME CORP. (US) 2013-03-28 WO disclosed
WO-2013043624-A1 SUBSTITUTED PYRIMIDINES MERCK SHARP & DOHME CORP. (US) 2013-03-28 WO disclosed
WO-2013040790-A1 SUBSTITUTED PYRIMIDINES MERCK SHARP & DOHME CORP. (US) 2013-03-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140349972-A1 SUBSTITUTED PYRIMIDINES HIF1AN, HIF1A, EGLN3 ALDH1A1 586/4885ALDH1A3 1520/4885ALDH3A1 395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.